secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2026-01-22T23:59:59+00:00
Accession:  0001213900-26-006448
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex Healthcare forms Clinical Advisory Board for PSX-001 anxiety program
-----------------------------------------------------------------------------

- Clinical Advisory Board (CAB) established to support PSX-001 development for generalized anxiety disorder.
- CAB will advise on trial design, endpoint selection, regulatory engagement, and strategic approach.
- Inaugural members: Dr. C. Neill Epperson, Dr. Charles B. Nemeroff, and Dr. Alan F. Schatzberg.
- CMO Dr. Lou Barbato says CAB will help inform key development decisions and support shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/0001213900-26-006448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026006448/ea0273695-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-006448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer